NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma

Shuming Hu1, Yuan Yuan2, Ruihan Yan1

  • 1Department of Biochemistry & Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Insights

Nuclear factor erythroid 2-related factor 2 (NRF2) regulates Epidermal Growth Factor (EGF) stability in lung adenocarcinoma. NRF2 activates OTUD4, which deubiquitinates and stabilizes EGF, promoting tumor progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Nuclear factor erythroid 2-related factor 2 (NRF2) is a transcription factor crucial for cellular antioxidant response and tumor progression.
  • NRF2 influences various cellular processes, including metabolism and biosynthesis, and its role in lung adenocarcinoma (LUAD) is significant.

Purpose of the Study:

  • To elucidate the novel mechanism by which NRF2 regulates Epidermal Growth Factor (EGF) stability in lung adenocarcinoma.
  • To investigate the role of deubiquitinases in the NRF2-EGF regulatory pathway.

Main Methods:

  • Modulation of NRF2 expression in LUAD cells (A549).
  • Identification and analysis of EGF ubiquitination status.
  • Prediction and validation of deubiquitinase (OTUD4) interaction with NRF2.
  • Analysis of NRF2 binding to the OTUD4 promoter and its transcriptional activation.
  • Correlation analysis of NRF2 and OTUD4 expression in LUAD patient data.

Main Results:

  • NRF2 modulates EGF expression at the protein level in LUAD cells.
  • EGF was identified as a ubiquitinated protein, and OTUD4 showed the highest correlation with NRF2.
  • NRF2 directly binds to the OTUD4 promoter, transcriptionally activating OTUD4 expression.
  • Activated OTUD4 promotes EGF deubiquitination and enhances EGF stability.
  • A significant correlation between OTUD4 and NRF2 expression was observed in LUAD patients.

Conclusions:

  • NRF2 enhances EGF stability through the deubiquitinase OTUD4 in lung adenocarcinoma.
  • This novel regulatory axis highlights a potential therapeutic target for LUAD treatment.
  • The findings reveal a new mechanism linking NRF2, OTUD4, and EGF in cancer progression.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K